VIM and malignant colon neoplasm: In order to verify that the present therapeutic strategy has a notable value in colon cancer patients, a local cohort of tumor samples from individuals diagnosed with colon cancer, stages 3/4, was analyzed for CDH1, VIM, and ZEB1 expression, these three genes representing the most important markers of EMT25.